Atlas Trials

A Multicenter, Open-Label Continuation Trial Evaluating the Tolerability and Activity of Depsipeptide (FK228) in Patients That Have Completed a Prior Clinical Study With Depsipeptide.

Clinical trial NCT00299351 · UNKNOWN

Trial details

NCT number
NCT00299351
Sponsor
Royal Marsden NHS Foundation Trust
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Peripheral T Cell Lymphoma (PTCL)
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.